Investor Update and R&D Tax Rebate
Filed with ASX · · 3 pages · English
Anatara Lifesciences Ltd on 6ix
Earlier from Anatara Lifesciences
- Zoetis Second Payment is received
- Investor Update
- R&D Tax Refund
- APVMA Submission Major Milestone Achieved
- Successful Completion of Target Safety Study
Later from Anatara Lifesciences
- ANR and Zoetis to negotiate International Detach Commercial
- Preliminary Final Report
- Pork CRC Options extended by 12 Months
- R&D Tax Incentive Received
- FDA approves the Human Food Safety Dossier
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences